Table 2 Patient characteristics
|  | Number of patients (n = 37) (%) |
|---|---|
Median age (range) | 50 (23–70) |
Gender | |
  Male | 23 (62.2) |
  Female | 14 (37.8) |
Diagnosis | |
  Acute myeloid leukemia | 9 (24.3) |
  Acute lymphocytic leukemia | 3 (8.1) |
  Acute biphenotypic leukemia | 1 (2.7) |
  Malignant lymphoma | 20 (54.1) |
  ATLL | 3 (8.1) |
  Myelodysplastic syndrome | 1 (2.7) |
Medical treatment | |
  Allogeneic BMT | 7 (18.9) |
  Autologous PBSCT | 4 (10.8) |
  Allogeneic PBSCT | 1 (2.7) |
  CBT | 2 (5.4) |
  Chemotherapy alone | 23 (62.2) |
Myelosuppression grading [courses]* | |
  Grade B | 34 (91.9) [64] |
  Grade C | 18 (48.6) [22] |
  Grade D | 15 (40.5) [15] |